HK Stock MarketDetailed Quotes

SUCCESSUNIVERSE (00487)

Watchlist
  • 0.043
  • -0.004-8.51%
Not Open Apr 24 15:34 CST
211.84MMarket Cap-0.52P/E (TTM)

SUCCESSUNIVERSE (00487) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
16.29%59.74M
-10.85%28.99M
-49.59%51.37M
-52.49%32.52M
-11.22%101.9M
25.50%68.44M
-24.05%114.78M
54.13%54.54M
-58.46%151.13M
-89.40%35.38M
Operating income
16.29%59.74M
-10.85%28.99M
-49.59%51.37M
-52.49%32.52M
-11.22%101.9M
25.50%68.44M
-24.05%114.78M
54.13%54.54M
-58.46%151.13M
-89.40%35.38M
Cost of sales
-20.23%-40.99M
16.69%-19.68M
59.95%-34.09M
61.25%-23.63M
16.84%-85.12M
-23.82%-60.97M
28.07%-102.35M
-58.23%-49.24M
58.92%-142.3M
90.37%-31.12M
Operating expenses
-20.23%-40.99M
16.69%-19.68M
59.95%-34.09M
61.25%-23.63M
16.84%-85.12M
-23.82%-60.97M
28.07%-102.35M
-58.23%-49.24M
58.92%-142.3M
90.37%-31.12M
Gross profit
8.50%18.75M
4.67%9.31M
2.98%17.28M
18.91%8.89M
35.05%16.78M
41.18%7.48M
40.67%12.42M
24.20%5.3M
-49.42%8.83M
-59.91%4.26M
Administrative expenses
3.19%-54.13M
9.44%-23.55M
-10.74%-55.91M
-10.73%-26.01M
-1.85%-50.49M
-8.34%-23.49M
-6.66%-49.58M
7.21%-21.68M
7.80%-46.48M
8.90%-23.36M
Profit from asset sales
----
----
----
----
----
----
----
----
---143K
----
Revaluation surplus
-84.59%9.93M
-16.00%-54.54M
-26.83%64.46M
-144.34%-47.01M
147.90%88.09M
210.53%106.02M
-291.93%-183.91M
-3,950.66%-95.92M
85.28%95.83M
106.17%2.49M
-Changes in the fair value of investment property
33.20%-16.5M
39.53%-5.2M
-238.36%-24.7M
-1,820.00%-8.6M
25.51%-7.3M
-54.55%500K
-220.99%-9.8M
-88.54%1.1M
110.20%8.1M
117.84%9.6M
-Changes in the fair value of financial assets
-70.35%26.43M
-28.43%-49.34M
-6.53%89.16M
-136.40%-38.41M
154.79%95.39M
208.76%105.52M
-298.48%-174.11M
-1,264.75%-97.02M
-33.10%87.73M
-152.83%-7.11M
Special items of operating profit
-2,058.50%-359.2M
86.29%-2.12M
-554.64%-16.64M
-492.82%-15.48M
76.52%-2.54M
405.91%3.94M
-462.14%-10.83M
135.33%779K
133.51%2.99M
77.63%-2.21M
Operating profit
-4,289.12%-384.65M
10.94%-70.9M
-82.29%9.18M
-184.73%-79.61M
122.35%51.84M
184.25%93.95M
-480.00%-231.89M
-492.82%-111.52M
519.73%61.03M
71.15%-18.81M
Financing cost
20.30%-22.65M
18.36%-11.69M
-6.17%-28.42M
-19.01%-14.31M
-95.77%-26.77M
-158.20%-12.03M
-66.86%-13.67M
-16.16%-4.66M
-23.62%-8.2M
-19.74%-4.01M
Share of profits of associates
-103.36%-3.77M
-16.53%48.54M
-22.10%111.95M
-18.83%58.15M
441.10%143.72M
845.84%71.64M
13.40%-42.13M
68.27%-9.61M
66.61%-48.65M
52.72%-30.27M
Share of profit from joint venture company
-0.73%677K
15.38%345K
31.66%682K
15.00%299K
-17.38%518K
-18.75%260K
-8.20%627K
-3.61%320K
19.61%683K
-0.30%332K
Earning before tax
-539.43%-410.39M
4.98%-33.71M
-44.84%93.39M
-123.06%-35.47M
158.98%169.3M
222.60%153.82M
-6,008.05%-287.07M
-137.79%-125.47M
103.42%4.86M
60.11%-52.76M
After-tax profit from continuing operations
-539.43%-410.39M
4.98%-33.71M
-44.84%93.39M
-123.06%-35.47M
158.98%169.3M
222.60%153.82M
-6,008.05%-287.07M
-137.79%-125.47M
103.42%4.86M
60.11%-52.76M
Earning after tax
-539.43%-410.39M
4.98%-33.71M
-44.84%93.39M
-123.06%-35.47M
158.98%169.3M
222.60%153.82M
-6,008.05%-287.07M
-137.79%-125.47M
103.42%4.86M
60.11%-52.76M
Profit attributable to shareholders
-539.43%-410.39M
4.98%-33.71M
-44.84%93.39M
-123.06%-35.47M
158.98%169.3M
222.60%153.82M
-6,008.05%-287.07M
-137.79%-125.47M
103.42%4.86M
60.11%-52.76M
Basic earnings per share
-538.42%-0.0833
5.56%-0.0068
-44.77%0.019
-123.08%-0.0072
159.01%0.0344
222.35%0.0312
-5,930.00%-0.0583
-138.32%-0.0255
103.47%0.001
60.07%-0.0107
Diluted earnings per share
-538.42%-0.0833
5.56%-0.0068
-44.77%0.019
-123.08%-0.0072
159.01%0.0344
222.35%0.0312
-5,930.00%-0.0583
-138.32%-0.0255
103.47%0.001
60.07%-0.0107
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 16.29%59.74M-10.85%28.99M-49.59%51.37M-52.49%32.52M-11.22%101.9M25.50%68.44M-24.05%114.78M54.13%54.54M-58.46%151.13M-89.40%35.38M
Operating income 16.29%59.74M-10.85%28.99M-49.59%51.37M-52.49%32.52M-11.22%101.9M25.50%68.44M-24.05%114.78M54.13%54.54M-58.46%151.13M-89.40%35.38M
Cost of sales -20.23%-40.99M16.69%-19.68M59.95%-34.09M61.25%-23.63M16.84%-85.12M-23.82%-60.97M28.07%-102.35M-58.23%-49.24M58.92%-142.3M90.37%-31.12M
Operating expenses -20.23%-40.99M16.69%-19.68M59.95%-34.09M61.25%-23.63M16.84%-85.12M-23.82%-60.97M28.07%-102.35M-58.23%-49.24M58.92%-142.3M90.37%-31.12M
Gross profit 8.50%18.75M4.67%9.31M2.98%17.28M18.91%8.89M35.05%16.78M41.18%7.48M40.67%12.42M24.20%5.3M-49.42%8.83M-59.91%4.26M
Administrative expenses 3.19%-54.13M9.44%-23.55M-10.74%-55.91M-10.73%-26.01M-1.85%-50.49M-8.34%-23.49M-6.66%-49.58M7.21%-21.68M7.80%-46.48M8.90%-23.36M
Profit from asset sales -----------------------------------143K----
Revaluation surplus -84.59%9.93M-16.00%-54.54M-26.83%64.46M-144.34%-47.01M147.90%88.09M210.53%106.02M-291.93%-183.91M-3,950.66%-95.92M85.28%95.83M106.17%2.49M
-Changes in the fair value of investment property 33.20%-16.5M39.53%-5.2M-238.36%-24.7M-1,820.00%-8.6M25.51%-7.3M-54.55%500K-220.99%-9.8M-88.54%1.1M110.20%8.1M117.84%9.6M
-Changes in the fair value of financial assets -70.35%26.43M-28.43%-49.34M-6.53%89.16M-136.40%-38.41M154.79%95.39M208.76%105.52M-298.48%-174.11M-1,264.75%-97.02M-33.10%87.73M-152.83%-7.11M
Special items of operating profit -2,058.50%-359.2M86.29%-2.12M-554.64%-16.64M-492.82%-15.48M76.52%-2.54M405.91%3.94M-462.14%-10.83M135.33%779K133.51%2.99M77.63%-2.21M
Operating profit -4,289.12%-384.65M10.94%-70.9M-82.29%9.18M-184.73%-79.61M122.35%51.84M184.25%93.95M-480.00%-231.89M-492.82%-111.52M519.73%61.03M71.15%-18.81M
Financing cost 20.30%-22.65M18.36%-11.69M-6.17%-28.42M-19.01%-14.31M-95.77%-26.77M-158.20%-12.03M-66.86%-13.67M-16.16%-4.66M-23.62%-8.2M-19.74%-4.01M
Share of profits of associates -103.36%-3.77M-16.53%48.54M-22.10%111.95M-18.83%58.15M441.10%143.72M845.84%71.64M13.40%-42.13M68.27%-9.61M66.61%-48.65M52.72%-30.27M
Share of profit from joint venture company -0.73%677K15.38%345K31.66%682K15.00%299K-17.38%518K-18.75%260K-8.20%627K-3.61%320K19.61%683K-0.30%332K
Earning before tax -539.43%-410.39M4.98%-33.71M-44.84%93.39M-123.06%-35.47M158.98%169.3M222.60%153.82M-6,008.05%-287.07M-137.79%-125.47M103.42%4.86M60.11%-52.76M
After-tax profit from continuing operations -539.43%-410.39M4.98%-33.71M-44.84%93.39M-123.06%-35.47M158.98%169.3M222.60%153.82M-6,008.05%-287.07M-137.79%-125.47M103.42%4.86M60.11%-52.76M
Earning after tax -539.43%-410.39M4.98%-33.71M-44.84%93.39M-123.06%-35.47M158.98%169.3M222.60%153.82M-6,008.05%-287.07M-137.79%-125.47M103.42%4.86M60.11%-52.76M
Profit attributable to shareholders -539.43%-410.39M4.98%-33.71M-44.84%93.39M-123.06%-35.47M158.98%169.3M222.60%153.82M-6,008.05%-287.07M-137.79%-125.47M103.42%4.86M60.11%-52.76M
Basic earnings per share -538.42%-0.08335.56%-0.0068-44.77%0.019-123.08%-0.0072159.01%0.0344222.35%0.0312-5,930.00%-0.0583-138.32%-0.0255103.47%0.00160.07%-0.0107
Diluted earnings per share -538.42%-0.08335.56%-0.0068-44.77%0.019-123.08%-0.0072159.01%0.0344222.35%0.0312-5,930.00%-0.0583-138.32%-0.0255103.47%0.00160.07%-0.0107
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More